📰
Read Full Article →Sourced From
TechCrunch
The round valued the AI biotech at $2 billion. It is currently testing drugs that treat skin conditions and preserve weight loss after stopping GLP-1s.
Source: TechCrunch — Read full article →
Content sourced from third parties. Copyright belongs to original publishers.


Leave a Reply